Sanofi Genzyme News |

Featured Press Releases

April 17, 2019
World Hemophilia Day: Sanofi Genzyme Donation Impacts Patients Across the Globe
On World Hemophilia Day April 17th, the global bleeding disorders community unites to raise awareness and understanding of hemophilia and areas of unmet needs for patients. Hemophilia is a rare, genetic bleeding disorder in which the ability of a person’s blood to clot is impaired, which can lead to...
April 8, 2019
Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance
Sanofi and Alnylam have agreed to conclude the research and option phase of the companies’ 2014 RNAi therapeutics alliance in rare genetic diseases. The material collaboration terms for patisiran, vutrisiran (ALN-TTRsc02) and fitusiran, as previously announced, will continue unchanged.
March 14, 2019
Sanofi Genzyme Launches Innovative and Educational Audio Adventure Series for People Treated with ALPROLIX®
Sanofi Genzyme, the specialty care business unit of Sanofi, today announced the launch of a first-of-its-kind audio adventure series designed to provide an engaging and educational infusion experience for ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] patients and their caregivers....
March 11, 2019
FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents
The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. Dupixent can be...

Leadership

Bill Sibold
Executive Vice President and Head of Sanofi Genzyme
Bill joined Sanofi Genzyme in 2011 as Senior Vice President and Head of Multiple Sclerosis, and oversaw the successful launches of its two MS treatments. As Head of Sanofi Genzyme, he leads the business’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology. More...

Tweets

So great to see monuments across the country #LightItUpRed tonight to raise awareness and support on… https://t.co/g5L8ZsuFVc-12 hours 10 min ago

On #WorldHemophiliaDay, @alliancerm released a new report on inherited blood disorders which focuses on areas we ar… https://t.co/VEdzoEpRAM-14 hours 3 min ago

Today is #WorldHemophiliaDay! We’re committed to developing therapies that address unmet needs in #hemophilia and o… https://t.co/pBZoeKO8q7-15 hours 46 min ago

On #WorldHemophiliaDay, our employees are taking part in Project Gratitude to show our appreciation for having the… https://t.co/aMAc2k7Yu8-16 hours 41 min ago

RT @hemophiliafed: Today is World Hemophilia Day, an international day to raise awareness for #hemophilia and #bleedingdisorders! This… https://t.co/oE5tf6fRRT-17 hours 24 min ago

Search Newsroom

Featured Press Releases

Featured Videos

Leadership

Media Resources

Tweets

Social Media